Literature DB >> 26555190

GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease.

Edgar R Kramer1, Birgit Liss2.   

Abstract

Glial cell line-derived neurotrophic factor (GDNF) and its canonical receptor Ret can signal together or independently to fulfill many important functions in the midbrain dopaminergic (DA) system. While Ret signaling clearly impacts on the development, maintenance and regeneration of the mesostriatal DA system, the physiological functions of GDNF for the DA system are still unclear. Nevertheless, GDNF is still considered to be an excellent candidate to protect and/or regenerate the mesostriatal DA system in Parkinson disease (PD). Clinical trials with GDNF on PD patients are, however, so far inconclusive. Here, we review the current knowledge of GDNF and Ret signaling and function in the midbrain DA system, and their crosstalk with proteins and signaling pathways associated with PD.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dopaminergic system; Drug addiction; Glia cell line-derived neurotrophic factor; Mouse model; Parkinson disease; Rearranged during transfection

Mesh:

Substances:

Year:  2015        PMID: 26555190     DOI: 10.1016/j.febslet.2015.11.006

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  33 in total

1.  RET isoforms contribute differentially to invasive processes in pancreatic ductal adenocarcinoma.

Authors:  Eric Y Lian; Brandy D Hyndman; Serisha Moodley; Sarah M Maritan; Lois M Mulligan
Journal:  Oncogene       Date:  2020-09-03       Impact factor: 9.867

2.  Impact of Auditory Integration Therapy (AIT) on the Plasma Levels of Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) in Autism Spectrum Disorder.

Authors:  Laila Al-Ayadhi; Afaf El-Ansary; Geir Bjørklund; Salvatore Chirumbolo; Gehan Ahmed Mostafa
Journal:  J Mol Neurosci       Date:  2019-05-09       Impact factor: 3.444

Review 3.  A focus on natural products for preventing and cure of mitochondrial dysfunction in Parkinson's disease.

Authors:  Abbas Mohammadipour
Journal:  Metab Brain Dis       Date:  2022-02-14       Impact factor: 3.584

Review 4.  The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.

Authors:  Niklas Reich; Christian Hölscher
Journal:  Front Neurosci       Date:  2022-09-01       Impact factor: 5.152

5.  Pretreatment with Perlecan-Conjugated Laminin-E8 Fragment Enhances Maturation of Grafted Dopaminergic Progenitors in Parkinson's Disease Model.

Authors:  Hiromasa Adachi; Asuka Morizane; Sadaharu Torikoshi; Fabian Raudzus; Yukimasa Taniguchi; Susumu Miyamoto; Kiyotoshi Sekiguchi; Jun Takahashi
Journal:  Stem Cells Transl Med       Date:  2022-07-20       Impact factor: 7.655

6.  Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson's Disease.

Authors:  C Requejo; J A Ruiz-Ortega; H Bengoetxea; S Bulnes; L Ugedo; J V Lafuente
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 7.  Glial Cell Line-Derived Neurotrophic Factor and Focal Ischemic Stroke.

Authors:  Zhe Zhang; Grace Y Sun; Shinghua Ding
Journal:  Neurochem Res       Date:  2021-02-16       Impact factor: 4.414

8.  Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model.

Authors:  Anja Drinkut; Karsten Tillack; Durga P Meka; Jorg B Schulz; Sebastian Kügler; Edgar R Kramer
Journal:  Cell Death Dis       Date:  2016-09-08       Impact factor: 8.469

Review 9.  Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.

Authors:  Johanna Duda; Christina Pötschke; Birgit Liss
Journal:  J Neurochem       Date:  2016-03-23       Impact factor: 5.372

10.  Striatal dopamine neurotransmission: regulation of release and uptake.

Authors:  David Sulzer; Stephanie J Cragg; Margaret E Rice
Journal:  Basal Ganglia       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.